|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 1900 for Pparg

0.045s
Type Details Score
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Tontonoz P
Year: 1994
Journal: Genes Dev
Title: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Volume: 8
Issue: 10
Pages: 1224-34
Publication
First Author: Zhu Y
Year: 1993
Journal: J Biol Chem
Title: Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
Volume: 268
Issue: 36
Pages: 26817-20
Publication
First Author: Ji S
Year: 2012
Journal: Biochem Biophys Res Commun
Title: O-GlcNAc modification of PPARĪ³ reduces its transcriptional activity.
Volume: 417
Issue: 4
Pages: 1158-63
Publication
First Author: Imai T
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse.
Volume: 101
Issue: 13
Pages: 4543-7
Publication
First Author: Parast MM
Year: 2009
Journal: PLoS One
Title: PPARgamma regulates trophoblast proliferation and promotes labyrinthine trilineage differentiation.
Volume: 4
Issue: 11
Pages: e8055
Publication
First Author: Lu J
Year: 2005
Journal: Cancer Res
Title: Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
Volume: 65
Issue: 11
Pages: 4769-74
Publication
First Author: Akune T
Year: 2004
Journal: J Clin Invest
Title: PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.
Volume: 113
Issue: 6
Pages: 846-55
Publication
First Author: Setoguchi K
Year: 2001
Journal: J Clin Invest
Title: Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis.
Volume: 108
Issue: 11
Pages: 1667-75
Publication
First Author: Muranaka K
Year: 2006
Journal: Invest Ophthalmol Vis Sci
Title: Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Volume: 47
Issue: 10
Pages: 4547-52
Publication
First Author: Asakawa M
Year: 2002
Journal: Circulation
Title: Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Volume: 105
Issue: 10
Pages: 1240-6
Publication
First Author: Yamauchi T
Year: 2001
Journal: J Clin Invest
Title: Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Volume: 108
Issue: 7
Pages: 1001-13
Publication
First Author: Nakajima A
Year: 2001
Journal: Gastroenterology
Title: Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.
Volume: 120
Issue: 2
Pages: 460-9
Publication
First Author: Matsui J
Year: 2004
Journal: Diabetes
Title: Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
Volume: 53
Issue: 11
Pages: 2844-54
Publication
First Author: Katafuchi T
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: PPARĪ³-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice.
Volume: 115
Issue: 48
Pages: 12102-12111
Publication
First Author: Calvier L
Year: 2017
Journal: Cell Metab
Title: PPARĪ³ Links BMP2 and TGFĪ²1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism.
Volume: 25
Issue: 5
Pages: 1118-1134.e7
Publication
First Author: Rodriguez-Cuenca S
Year: 2012
Journal: FASEB J
Title: Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses.
Volume: 26
Issue: 5
Pages: 1835-44
Publication
First Author: Virtue S
Year: 2018
Journal: Cell Rep
Title: Peroxisome Proliferator-Activated Receptor Ī³2 Controls the Rate of Adipose Tissue Lipid Storage and Determines Metabolic Flexibility.
Volume: 24
Issue: 8
Pages: 2005-2012.e7
Publication
First Author: Medina-Gomez G
Year: 2005
Journal: Diabetes
Title: The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform.
Volume: 54
Issue: 6
Pages: 1706-16
Publication
First Author: Rangwala SM
Year: 2003
Journal: Dev Cell
Title: Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.
Volume: 5
Issue: 4
Pages: 657-63
Publication  
First Author: Ge C
Year: 2018
Journal: Bone
Title: Genetic inhibition of PPARĪ³ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
Volume: 107
Pages: 1-9
Publication
First Author: Ro SH
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Sestrin2 inhibits uncoupling protein 1 expression through suppressing reactive oxygen species.
Volume: 111
Issue: 21
Pages: 7849-54
Publication
First Author: Freedman BD
Year: 2005
Journal: J Biol Chem
Title: A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.
Volume: 280
Issue: 17
Pages: 17118-25
Publication
First Author: Jones JR
Year: 2002
Journal: Genesis
Title: Generation and functional confirmation of a conditional null PPARgamma allele in mice.
Volume: 32
Issue: 2
Pages: 134-7
Publication
First Author: Jones JR
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.
Volume: 102
Issue: 17
Pages: 6207-12
Publication
First Author: Sarruf DA
Year: 2009
Journal: Endocrinology
Title: Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis.
Volume: 150
Issue: 2
Pages: 707-12
Publication
First Author: Domi E
Year: 2019
Journal: J Neurosci
Title: Activation of PPARĪ³ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.
Volume: 39
Issue: 49
Pages: 9864-9875
Publication
First Author: Tsai YS
Year: 2004
Journal: J Clin Invest
Title: Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
Volume: 114
Issue: 2
Pages: 240-9
Publication
First Author: Chang CS
Year: 2014
Journal: Am J Pathol
Title: Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.
Volume: 184
Issue: 2
Pages: 442-53
Publication
First Author: Beyer AM
Year: 2008
Journal: Hypertension
Title: Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.
Volume: 51
Issue: 4
Pages: 867-71
Publication
First Author: Wu JS
Year: 2009
Journal: Circulation
Title: Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation.
Volume: 119
Issue: 8
Pages: 1124-34
Publication
First Author: Rodriguez-Cuenca S
Year: 2018
Journal: Diabetes Obes Metab
Title: P465L-PPARĪ³ mutation confers partial resistance to the hypolipidaemic action of fibrates.
Volume: 20
Issue: 10
Pages: 2339-2350
Publication  
First Author: Gƶtz AA
Year: 2011
Journal: Part Fibre Toxicol
Title: Carbon-nanoparticle-triggered acute lung inflammation and its resolution are not altered in PPARĪ³-defective (P465L) mice.
Volume: 8
Pages: 28
Publication
First Author: Gray SL
Year: 2006
Journal: Endocrinology
Title: Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function.
Volume: 147
Issue: 12
Pages: 5708-14
Publication      
First Author: Chen Z
Year: 2018
Journal: MGI Direct Data Submission
Title: Mutagenetix entry for energy.
Publication
First Author: Sun H
Year: 2013
Journal: Stem Cells
Title: Osteoblast-targeted suppression of PPARĪ³ increases osteogenesis through activation of mTOR signaling.
Volume: 31
Issue: 10
Pages: 2183-92
Publication
First Author: Marchesi C
Year: 2013
Journal: Cardiovasc Res
Title: Protective role of vascular smooth muscle cell PPARĪ³ in angiotensin II-induced vascular disease.
Volume: 97
Issue: 3
Pages: 562-70
Publication
First Author: Caglayan E
Year: 2019
Journal: Respir Res
Title: Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor-Ī³ in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension.
Volume: 20
Issue: 1
Pages: 42
Publication
First Author: Idris-Khodja N
Year: 2017
Journal: J Hypertens
Title: Vascular smooth muscle cell peroxisome proliferator-activated receptor Ī³ protects against endothelin-1-induced oxidative stress and inflammation.
Volume: 35
Issue: 7
Pages: 1390-1401
Publication
First Author: Norris AW
Year: 2003
Journal: J Clin Invest
Title: Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
Volume: 112
Issue: 4
Pages: 608-18
Publication
First Author: Adachi M
Year: 2006
Journal: Gut
Title: Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Volume: 55
Issue: 8
Pages: 1104-13
Publication
First Author: Peng K
Year: 2017
Journal: Am J Physiol Renal Physiol
Title: Collecting duct (pro)renin receptor targets ENaC to mediate angiotensin II-induced hypertension.
Volume: 312
Issue: 2
Pages: F245-F253
Publication
First Author: Ding G
Year: 2007
Journal: Cardiovasc Res
Title: Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage.
Volume: 76
Issue: 2
Pages: 269-79
Publication
First Author: Ivashchenko CY
Year: 2007
Journal: Am J Physiol Gastrointest Liver Physiol
Title: PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
Volume: 293
Issue: 1
Pages: G319-26
Publication
First Author: Zhang H
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.
Volume: 102
Issue: 26
Pages: 9406-11
Publication
First Author: Nicol CJ
Year: 2004
Journal: Carcinogenesis
Title: PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.
Volume: 25
Issue: 9
Pages: 1747-55
Publication
First Author: Zingarelli B
Year: 2008
Journal: Immunology
Title: Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.
Volume: 124
Issue: 1
Pages: 51-7
Publication
First Author: Gupta D
Year: 2010
Journal: Diabetes
Title: Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.
Volume: 59
Issue: 6
Pages: 1445-50
Publication  
First Author: Cao J
Year: 2015
Journal: Mol Cell Endocrinol
Title: Impact of targeted PPARĪ³ disruption on bone remodeling.
Volume: 410
Pages: 27-34
Publication
First Author: Nicol CJ
Year: 2005
Journal: Am J Hypertens
Title: PPARgamma in endothelial cells influences high fat diet-induced hypertension.
Volume: 18
Issue: 4 Pt 1
Pages: 549-56
Publication
First Author: Apostoli AJ
Year: 2014
Journal: Int J Cancer
Title: Loss of PPARĪ³ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.
Volume: 134
Issue: 5
Pages: 1055-66
Publication
First Author: Zhou L
Year: 2015
Journal: Physiol Genomics
Title: Systemic PPARĪ³ deletion causes severe disturbance in fluid homeostasis in mice.
Volume: 47
Issue: 11
Pages: 541-7
Publication
First Author: Simon DM
Year: 2006
Journal: FASEB J
Title: Epithelial cell PPAR[gamma] contributes to normal lung maturation.
Volume: 20
Issue: 9
Pages: 1507-9
Publication
First Author: Dai Y
Year: 2009
Journal: Cancer Res
Title: Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Volume: 69
Issue: 11
Pages: 4776-83
Publication
First Author: Gavrilova O
Year: 2003
Journal: J Biol Chem
Title: Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
Volume: 278
Issue: 36
Pages: 34268-76
Publication
First Author: He H
Year: 2014
Journal: Toxicol Sci
Title: Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor Ī³-independent mitochondrial oxidative stress in mouse hearts.
Volume: 138
Issue: 2
Pages: 468-81
Publication
First Author: Barbieri M
Year: 2012
Journal: PLoS One
Title: Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-Ī³-knockout (CM-PGKO) mice.
Volume: 7
Issue: 4
Pages: e35999
Publication
First Author: Kanda T
Year: 2009
Journal: J Clin Invest
Title: PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.
Volume: 119
Issue: 1
Pages: 110-24
Publication
First Author: Duan SZ
Year: 2005
Journal: Circ Res
Title: Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
Volume: 97
Issue: 4
Pages: 372-9
Publication
First Author: Welters HJ
Year: 2012
Journal: Endocrinology
Title: Rosiglitazone promotes PPARĪ³-dependent and -independent alterations in gene expression in mouse islets.
Volume: 153
Issue: 10
Pages: 4593-9
Publication
First Author: Barak Y
Year: 1999
Journal: Mol Cell
Title: PPAR gamma is required for placental, cardiac, and adipose tissue development.
Volume: 4
Issue: 4
Pages: 585-95
Publication
First Author: Miles PD
Year: 2003
Journal: Am J Physiol Endocrinol Metab
Title: Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding.
Volume: 284
Issue: 3
Pages: E618-26
Publication
First Author: Tai HC
Year: 2016
Journal: Hypertension
Title: Peroxisome Proliferator-Activated Receptor Ī³ Level Contributes to Structural Integrity and Component Production of Elastic Fibers in the Aorta.
Volume: 67
Issue: 6
Pages: 1298-308
Publication
First Author: Natarajan C
Year: 2003
Journal: J Immunol
Title: Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
Volume: 171
Issue: 11
Pages: 5743-50
Publication
First Author: Miles PD
Year: 2000
Journal: J Clin Invest
Title: Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
Volume: 105
Issue: 3
Pages: 287-92
Publication
First Author: Skelhorne-Gross G
Year: 2012
Journal: Carcinogenesis
Title: Stromal adipocyte PPARĪ³ protects against breast tumorigenesis.
Volume: 33
Issue: 7
Pages: 1412-20
Publication
First Author: Cui Y
Year: 2002
Journal: J Biol Chem
Title: Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility.
Volume: 277
Issue: 20
Pages: 17830-5
Publication
First Author: Evans NP
Year: 2010
Journal: J Nutr
Title: Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.
Volume: 140
Issue: 3
Pages: 515-21
Publication
First Author: Mohapatra SK
Year: 2010
Journal: PLoS One
Title: Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.
Volume: 5
Issue: 4
Pages: e10215
Publication  
First Author: Hensler M
Year: 2011
Journal: Lipids Health Dis
Title: The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice.
Volume: 10
Pages: 128
Publication  
First Author: Chen T
Year: 2017
Journal: Sci Immunol
Title: PPAR-Ī³ promotes type 2 immune responses in allergy and nematode infection.
Volume: 2
Issue: 9
Publication  
First Author: Duszka K
Year: 2016
Journal: Sci Rep
Title: Intestinal PPARĪ³ signalling is required for sympathetic nervous system activation in response to caloric restriction.
Volume: 6
Pages: 36937
Publication
First Author: Tomas J
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: High-fat diet modifies the PPAR-Ī³ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.
Volume: 113
Issue: 40
Pages: E5934-E5943
Publication
First Author: Fumery M
Year: 2017
Journal: EMBO Mol Med
Title: Peroxisome proliferator-activated receptor gamma (PPARĪ³) regulates lactase expression and activity in the gut.
Volume: 9
Issue: 11
Pages: 1471-1481
Publication
First Author: Zhang J
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
Volume: 101
Issue: 29
Pages: 10703-8
Publication
First Author: Koutnikova H
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.
Volume: 100
Issue: 24
Pages: 14457-62
Publication
First Author: Heikkinen S
Year: 2009
Journal: Cell Metab
Title: The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface.
Volume: 9
Issue: 1
Pages: 88-98
Publication
First Author: Hall JA
Year: 2020
Journal: Cell Metab
Title: Obesity-Linked PPARĪ³ S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3.
Volume: 32
Issue: 4
Pages: 665-675.e6
Publication
First Author: Jiang M
Year: 2010
Journal: Cell Death Differ
Title: Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.
Volume: 17
Issue: 3
Pages: 469-81
Publication  
First Author: Park HJ
Year: 2016
Journal: Sci Rep
Title: Gender-specific differences in PPARĪ³ regulation of follicular helper T cell responses with estrogen.
Volume: 6
Pages: 28495
Publication
First Author: Klotz L
Year: 2009
Journal: J Exp Med
Title: The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.
Volume: 206
Issue: 10
Pages: 2079-89
Publication
First Author: He W
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
Volume: 100
Issue: 26
Pages: 15712-7
Publication  
First Author: Xu M
Year: 2021
Journal: Front Immunol
Title: Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARĪ³ Dependent Manner.
Volume: 12
Pages: 618501
Publication
First Author: Long L
Year: 2014
Journal: J Clin Invest
Title: PPARĪ³ ablation sensitizes proopiomelanocortin neurons to leptin during high-fat feeding.
Volume: 124
Issue: 9
Pages: 4017-27
Publication
First Author: Park HJ
Year: 2014
Journal: PLoS One
Title: PPARĪ³ negatively regulates T cell activation to prevent follicular helper T cells and germinal center formation.
Volume: 9
Issue: 6
Pages: e99127
Publication
First Author: Zhao X
Year: 2009
Journal: J Neurosci
Title: Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia.
Volume: 29
Issue: 19
Pages: 6186-95
Publication
First Author: Wan Y
Year: 2007
Journal: Genes Dev
Title: Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.
Volume: 21
Issue: 15
Pages: 1895-908
Publication
First Author: Yu SJ
Year: 2012
Journal: Psychopharmacology (Berl)
Title: Suppression of endogenous PPARĪ³ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.
Volume: 221
Issue: 3
Pages: 479-92
Publication
First Author: Fernandez MO
Year: 2017
Journal: Endocrinology
Title: Obese Neuronal PPARĪ³ Knockout Mice Are Leptin Sensitive but Show Impaired Glucose Tolerance and Fertility.
Volume: 158
Issue: 1
Pages: 121-133
Publication
First Author: Fernandez MO
Year: 2017
Journal: J Endocr Soc
Title: Astrocyte-Specific Deletion of Peroxisome-Proliferator Activated Receptor-Ī³ Impairs Glucose Metabolism and Estrous Cycling in Female Mice.
Volume: 1
Issue: 11
Pages: 1332-1350
Publication  
First Author: Xu L
Year: 2018
Journal: Aging Cell
Title: Ablation of PPARĪ³ in subcutaneous fat exacerbates age-associated obesity and metabolic decline.
Volume: 17
Issue: 2
Publication
First Author: Yeligar SM
Year: 2016
Journal: Am J Respir Cell Mol Biol
Title: Peroxisome Proliferator-Activated Receptor Ī³ Regulates Chronic Alcohol-Induced Alveolar Macrophage Dysfunction.
Volume: 55
Issue: 1
Pages: 35-46
Publication  
First Author: Legchenko E
Year: 2018
Journal: Sci Transl Med
Title: PPARĪ³ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
Volume: 10
Issue: 438
Publication
First Author: Shao M
Year: 2021
Journal: Cell Stem Cell
Title: Pathologic HIF1Ī± signaling drives adipose progenitor dysfunction in obesity.
Volume: 28
Issue: 4
Pages: 685-701.e7
Publication
First Author: Wang F
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARĪ³.
Volume: 110
Issue: 46
Pages: 18656-61